newsfilter
← Latest News
GlobeNewswire·

BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update

JERUSALEM, Nov. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), which focuses on developing, manufacturing, and commercializing innovative immunotherapeutic products